Remote, real-time alerts for generalized tonic-clonic seizures
Embrace2 is the world’s only FDA-cleared wrist-worn wearable in epilepsy. It continuously monitors physiological signals and instantly alerts family, friends, and caregivers in case of a possible seizure. Discover all you need to know to confidently prescribe Embrace2 alerting to your patients.
Our products are trusted by the world’s most renowned pharmaceutical companies, hospitals and academics.
A beautiful medical device
for everyday life
Embrace2 has been FDA-cleared for both adults and children ages 6 and above. Now patients can take medical monitoring beyond the hospital and into the home.
With our Remote Seizure Monitoring service, physicians can take advantage of the unique detection and data collection capabilities of Embrace2 to review objective seizure data, and get reimbursed by Medicare.
Help when your patients
need it most
Benefits both doctors and patients
Embrace2 enhances the relationship between doctors and their patients by allowing for more focused dialogue. Patients can share detailed data immediately, so doctors have a broader view of their health and can provide more tailored solutions.
Peace of mind for patients
Decrease seizure-related injuries: A study of 71 epilepsy patients using a wearable alert device at home showed that in 40% of the patients, the device contributed to achieving fewer seizure-related injuries1
Round-the-clock monitoring with 48+ hours battery life
More likely that a patient is attended to, as alerts are sent remotely with a GPS location
Stylish and discreet design that fits your patient's daily needs
Accurate data for doctors
Improved seizure counts: FDA-cleared devices show much higher sensitivity, with the lower bound of the 95% confidence interval reaching 92% for GTCS detection2, 3
Easy access to an accurate digital seizure diary, including seizure time and duration (see Mate App)
Observe patient seizure activity, rest patterns and quality of rest in a single view
Only device on the market to monitor
Embrace measures both movement and autonomic activity. The sympathetic branch of the autonomic nervous system innervates the skin, causing changes in the skin known as electrodermal activity (EDA). Embrace uses artificial intelligence to run advanced machine learning inside the watch, continuously examining the EDA and motion, in order to detect patterns that usually occur with generalized tonic-clonic seizures (GTCS).
Combining motion and EDA, the Embrace provides alerts with higher sensitivity and fewer false alarms than devices that use only motion.
What is EDA
EDA, or electrodermal activity, refers to electrical changes in the skin, which are elicited by the sympathetic nervous system.
Eda in seizure detection
Generalized tonic-clonic seizures often have a rise in EDA; the size of the EDA increase is correlated with the duration of post-ictal EEG suppression. Therefore, using EDA in our algorithm makes it more accurate and decreases false alarms.
There's a plan for everyone
Our subscription plans offer patients the flexibility to try out new features, and easily switch plans anytime they want. All of them provide seizure alerting capabilities. Users have the opportunity to try out the device on the Plus plan for 30 days for free, and return it if it doesn't suit their needs.
Getting Embrace2 reimbursed by insurance depends on your specific plan and coverage level. Advise your patient to contact their insurer, for any questions regarding insurance coverage of the subscription plan. For more information regarding reimbursement share this article with your patient.